Yanqi Dang

1.2k total citations
41 papers, 878 citations indexed

About

Yanqi Dang is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Yanqi Dang has authored 41 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Epidemiology and 12 papers in Cancer Research. Recurrent topics in Yanqi Dang's work include Liver Disease Diagnosis and Treatment (14 papers), Cancer-related molecular mechanisms research (7 papers) and Gut microbiota and health (6 papers). Yanqi Dang is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Cancer-related molecular mechanisms research (7 papers) and Gut microbiota and health (6 papers). Yanqi Dang collaborates with scholars based in China, Canada and United States. Yanqi Dang's co-authors include Guang Ji, Wenjun Zhou, Zhenhua Yang, Mingzhe Zhu, Wenjun Zhou, Li Zhang, Meng Li, Yangxian Xu, Guo‐Qiang Lin and Pan Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Yanqi Dang

38 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanqi Dang China 20 494 249 171 114 114 41 878
Daniel E. Francés Argentina 20 384 0.8× 276 1.1× 83 0.5× 137 1.2× 100 0.9× 38 950
Yamei Han China 14 599 1.2× 361 1.4× 104 0.6× 129 1.1× 206 1.8× 37 1.1k
Siavash Mansouri Iran 17 248 0.5× 215 0.9× 97 0.6× 87 0.8× 120 1.1× 23 784
Qichao Hu China 16 412 0.8× 212 0.9× 137 0.8× 97 0.9× 59 0.5× 43 1.0k
Lei Dong China 16 424 0.9× 216 0.9× 155 0.9× 62 0.5× 66 0.6× 42 1.0k
Xuemei Gu China 17 390 0.8× 236 0.9× 69 0.4× 186 1.6× 167 1.5× 40 1.0k
Tian Zhang China 16 391 0.8× 233 0.9× 110 0.6× 46 0.4× 132 1.2× 40 826
Jaime Arellanes‐Robledo Mexico 18 361 0.7× 234 0.9× 92 0.5× 60 0.5× 61 0.5× 52 822

Countries citing papers authored by Yanqi Dang

Since Specialization
Citations

This map shows the geographic impact of Yanqi Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqi Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqi Dang more than expected).

Fields of papers citing papers by Yanqi Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqi Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqi Dang. The network helps show where Yanqi Dang may publish in the future.

Co-authorship network of co-authors of Yanqi Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqi Dang. A scholar is included among the top collaborators of Yanqi Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqi Dang. Yanqi Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jingyuan, et al.. (2025). Colorectal Cancer: Pathogenesis and Targeted Therapy. MedComm. 6(3). e70127–e70127. 10 indexed citations
3.
Zhou, Wenjun, et al.. (2024). Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies. SHILAP Revista de lepidopterología. 5(10). e752–e752. 1 indexed citations
4.
Zhang, Li, et al.. (2024). Gan-jiang-ling-zhu decoction improves steatohepatitis by regulating gut microbiota-mediated 12-tridecenoic acid inhibition. Frontiers in Pharmacology. 15. 1444561–1444561. 2 indexed citations
5.
Zhou, Wenjun, et al.. (2024). The role of N6-methyladenosine in macrophage polarization: A novel treatment strategy for non-alcoholic steatohepatitis. Biomedicine & Pharmacotherapy. 171. 116145–116145. 4 indexed citations
6.
Wang, Kai, et al.. (2024). Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice. Journal of Translational Medicine. 22(1). 1085–1085. 3 indexed citations
7.
Dang, Yanqi, et al.. (2023). tRNA‐derived fragments are promising biomarkers for screening of early colorectal cancer. SHILAP Revista de lepidopterología. 4(3). e227–e227. 4 indexed citations
8.
Zhu, Mingzhe, Xue Wang, Kai Wang, et al.. (2023). Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites. Frontiers in Cellular and Infection Microbiology. 13. 19 indexed citations
9.
Wang, Kai, et al.. (2023). Targeted metabolomics revealed the mechanisms underlying the role of Liansu capsule in ameliorating functional dyspepsia. Journal of Ethnopharmacology. 321. 117568–117568. 2 indexed citations
10.
Dang, Yanqi, et al.. (2022). Roles of gut microbiota and metabolites in overweight and obesity of children. Frontiers in Endocrinology. 13. 994930–994930. 29 indexed citations
11.
Zhou, Wenjun, et al.. (2022). Recent advances in lean NAFLD. Biomedicine & Pharmacotherapy. 153. 113331–113331. 65 indexed citations
12.
Dai, Liang, Baocheng Liu, Yanqi Dang, et al.. (2022). Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach. Frontiers of Medicine. 16(5). 745–759. 27 indexed citations
13.
Zhou, Wenjun, et al.. (2022). Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease. Biomedicine & Pharmacotherapy. 151. 113127–113127. 34 indexed citations
14.
Li, Chunlin, Li Zhang, Yanqi Dang, et al.. (2021). Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology. Biomedicine & Pharmacotherapy. 143. 112181–112181. 25 indexed citations
15.
Dai, Liang, Wenjun Zhou, Yanqi Dang, et al.. (2021). Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment. Frontiers in Pharmacology. 11. 620724–620724. 29 indexed citations
16.
Li, Qiong, Meng Li, Fenghua Li, et al.. (2020). Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. Journal of Ethnopharmacology. 258. 112896–112896. 29 indexed citations
17.
Dang, Yanqi, et al.. (2020). Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis. Biomedicine & Pharmacotherapy. 127. 110127–110127. 29 indexed citations
18.
Dang, Yanqi, et al.. (2019). The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules. BMC Complementary and Alternative Medicine. 19(1). 8–8. 30 indexed citations
19.
Yang, Zhenhua, Yanqi Dang, & Guang Ji. (2019). Role of epigenetics in transformation of inflammation into colorectal cancer. World Journal of Gastroenterology. 25(23). 2863–2877. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026